Legend Biotech IPO Initiation: Choosing Therapies À La CAR-T
Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
385 Views
BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion
Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...
491 Views
BBI Life: Privatisation Offer For DNA Synthesizer
Following a brief trading halt, BBI Life Sciences (1035 HK), the biggest supplier of DNA synthesis products in the PRC, announced a privatisation...
730 Views
Wuxi Biologics Placement -Â Probably Not a Surprise to Sell Again when Lock-Up Expires
Biologics Holdings is looking to sell 50m shares of WuXi Biologics (Cayman) Inc. (2269 HK) worth about US$500m. Post sale, Biologics Holdings will...
619 Views
Genscript Biotech Placement - Raising Money to Build Up CAR-T R&D and Production Facilities
Genscript Biotech Corp (1548 HK) is looking to raise US$304m by selling 90m shares (including 15m top-up primary shares). This is a concurrent...
268 Views